Susquehanna Fundamental Investments’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $691K | Hold |
108,310
| – | – | 0.02% | 505 |
|
|
2025
Q1 | $526K | Buy |
108,310
+9,579
| +10% | +$46.6K | 0.01% | 830 |
|
|
2024
Q4 | $944K | Buy |
+98,731
| New | +$944K | 0.01% | 719 |
|
|
2024
Q2 | $677K | Sell |
99,254
-19,393
| -16% | -$132K | 0.02% | 627 |
|
|
2024
Q1 | $300K | Buy |
+118,647
| New | +$300K | 0.01% | 554 |
|
|
2022
Q4 | – | Sell |
-114,214
| Closed | -$2.4M | – | 1275 |
|
|
2022
Q3 | $2.4M | Buy |
+114,214
| New | +$2.4M | 0.04% | 521 |
|
|
2022
Q1 | $1.11M | Buy |
26,941
+235
| +0.9% | +$9.65K | 0.02% | 792 |
|
|
2021
Q4 | $1.16M | Sell |
26,706
-12,221
| -31% | -$531K | 0.03% | 591 |
|
|
2021
Q3 | $1.95M | Buy |
+38,927
| New | +$1.95M | 0.04% | 606 |
|
|
2021
Q2 | – | Sell |
-21,896
| Closed | -$2.03M | – | 1682 |
|
|
2021
Q1 | $2.03M | Buy |
21,896
+3,768
| +21% | +$350K | 0.03% | 642 |
|
|
2020
Q4 | $1.62M | Buy |
18,128
+2,414
| +15% | +$216K | 0.03% | 690 |
|
|
2020
Q3 | $1.62M | Buy |
+15,714
| New | +$1.62M | 0.05% | 498 |
|